Cargando…

WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice

Hippo signaling acts as a tumor suppressor pathway by inhibiting the proliferation of adult stem cells and progenitor cells in various organs. Liver-specific deletion of Hippo pathway components in mice induces liver cancer development through activation of the transcriptional coactivators, YAP and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jaeoh, Kim, Jeong Sik, Nahm, Ji Hae, Kim, Sang-Kyum, Lee, Da-Hye, Lim, Dae-Sik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264477/ https://www.ncbi.nlm.nih.gov/pubmed/32451369 http://dx.doi.org/10.14348/molcells.2020.0093

Ejemplares similares

LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development
por: Lee, Da-Hye, et al.
Publicado: (2016)

Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth
por: Koo, Ja Hyun, et al.
Publicado: (2020)

YAP/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells
por: Choi, Sung Yong, et al.
Publicado: (2020)

The TGF(β)→TAK1→LATS→YAP1 Pathway Regulates the Spatiotemporal Dynamics of YAP1
por: Kim, Min-Kyu, et al.
Publicado: (2023)

Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma
por: Tóth, Marcell, et al.
Publicado: (2021)

Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression
por: Qian, Meijia, et al.
Publicado: (2021)

Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade
por: Lodge, Emily J, et al.
Publicado: (2019)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

OR24-4 Homeostatic and Tumourigenic Activity of SOX2+ Pituitary Stem Cells is Controlled by the LATS/YAP/TAZ Cascade
por: Lodge, Emily, et al.
Publicado: (2019)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

Pharmacological Activation of YAP/TAZ by Targeting LATS1/2 Enhances Periodontal Tissue Regeneration in a Murine Model
por: Sato, Akiko, et al.
Publicado: (2023)

DNA binding partners of YAP/TAZ
por: Kim, Min-Kyu, et al.
Publicado: (2018)

WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling
por: Han, Qiang, et al.
Publicado: (2018)

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
por: Cigliano, Antonio, et al.
Publicado: (2022)

SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma
por: Chai, Yuhang, et al.
Publicado: (2019)

YAP and TAZ regulate cell volume
por: Perez-Gonzalez, Nicolas A., et al.
Publicado: (2019)

Mechanisms of YAP/TAZ transcriptional control
por: Battilana, Giusy, et al.
Publicado: (2021)

YAP/TAZ in Bone and Cartilage Biology
por: Zarka, Mylène, et al.
Publicado: (2022)

YAP/TAZ dull the STING of aging
por: Francisco, Jamie, et al.
Publicado: (2022)

Nuclear Import and Export of YAP and TAZ
por: Kofler, Michael, et al.
Publicado: (2023)

A Case of Clonorchiasis with Focal Intrahepatic Duct Dilatation Mimicking an Intrahepatic Cholangiocarcinoma
por: Kim, Bong Gap, et al.
Publicado: (2011)

Reciprocal inhibition of YAP/TAZ and NF-κB regulates osteoarthritic cartilage degradation
por: Deng, Yujie, et al.
Publicado: (2018)

An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2
por: Park, Gun-Soo, et al.
Publicado: (2016)

Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
por: Cigliano, Antonio, et al.
Publicado: (2023)

β-Arrestin 2 suppresses the activation of YAP by promoting LATS kinase activity
por: Kim, Minsuh, et al.
Publicado: (2022)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

YAP/TAZ initiate and maintain Schwann cell myelination
por: Grove, Matthew, et al.
Publicado: (2017)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
por: Merritt, Nicole, et al.
Publicado: (2021)

Intrahepatic cholangiocarcinoma arising in Caroli's disease
por: Jang, Min Hye, et al.
Publicado: (2014)

TAZ and YAP are frequently activated oncoproteins in sarcomas
por: Fullenkamp, Colleen A., et al.
Publicado: (2016)

Multifaceted regulation and functions of YAP/TAZ in tumors
por: Liu, Huirong, et al.
Publicado: (2018)

YAP and TAZ are dispensable for physiological and malignant haematopoiesis
por: Donato, Elisa, et al.
Publicado: (2018)

The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
por: Azad, Taha, et al.
Publicado: (2019)

YAP and TAZ in Lung Development: The Timing Is Important
por: Warburton, David
Publicado: (2020)

Emerging Principles in the Transcriptional Control by YAP and TAZ
por: Lopez-Hernandez, Alejandro, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

YAP/TAZ: Molecular pathway and disease therapy
por: Wei, Yuzi, et al.
Publicado: (2023)

WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression
por: Han, Qiang, et al.
Publicado: (2021)

The SRF-YAP-IL6 axis promotes breast cancer stemness
por: Kim, Tackhoon, et al.
Publicado: (2016)

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_74uubgdpigtguga3vb0tjjh952